Publications
Detailed Information
The association of fatty liver index and BARD score with all-cause and cause-specific mortality in patients with type 2 diabetes mellitus: a nationwide population-based study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chung, Goh Eun | - |
dc.contributor.author | Jeong, Su-Min | - |
dc.contributor.author | Cho, Eun Ju | - |
dc.contributor.author | Yoon, Ji Won | - |
dc.contributor.author | Yoo, Jeong-Ju | - |
dc.contributor.author | Cho, Yuri | - |
dc.contributor.author | Lee, Kyu-na | - |
dc.contributor.author | Shin, Dong Wook | - |
dc.contributor.author | Kim, Yoon Jun | - |
dc.contributor.author | Yoon, Jung-Hwan | - |
dc.contributor.author | Han, Kyungdo | - |
dc.contributor.author | Yu, Su Jong | - |
dc.date.accessioned | 2022-12-27T04:41:40Z | - |
dc.date.available | 2022-12-27T13:42:14Z | - |
dc.date.issued | 2022-12-06 | - |
dc.identifier.citation | Cardiovascular Diabetology, 21(1):273 | ko_KR |
dc.identifier.issn | 1475-2840 | - |
dc.identifier.uri | https://doi.org/10.1186/s12933-022-01691-6 | - |
dc.identifier.uri | https://hdl.handle.net/10371/187362 | - |
dc.description.abstract | Background
Type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) commonly coexist. However, NAFLDs effect on mortality in Asian patients with type 2 diabetes awaits full elucidation. Therefore, we examined NAFLD-related all-cause and cause-specific mortality in a nationwide Asian population with type 2 diabetes. Methods We included patients who had undergone general health checkups between 2009 and 2012 using the National Health Insurance Service database linked to death-certificate data. Hepatic steatosis was defined as a fatty liver index (FLI) ≥ 60, and advanced hepatic fibrosis was determined using the BARD score. Findings During the follow-up period of 8.1years, 222,242 deaths occurred, with a mortality rate of 14.3/1000 person-years. An FLI ≥ 60 was significantly associated with increased risks of all-cause and cause-specific mortality including cardiovascular disease (CVD)-, cancer-, and liver disease (FLI ≥ 60: hazard ratio [HR] = 1.02, 95% confidence interval [CI] 1.01–1.03 for all-cause; 1.07, 1.04–1.10 for CVD; 1.12, 1.09–1.14 for cancer; and 2.63, 2.50–2.77 for liver disease). Those with an FLI ≥ 60 and fibrosis (BARD ≥ 2) exhibited increased risks of all-cause (HR, 95% CI 1.11, 1.10–1.12), CVD- (HR, 95% CI 1.11, 1.09–1.14), cancer- (HR, 95% CI 1.17, 1.15–1.19), and liver disease-related (HR, 95% CI 2.38, 2.29–2.49) mortality. Conclusion Hepatic steatosis and advanced fibrosis were significantly associated with risks of overall and cause-specific mortality in patients with type 2 diabetes. Our results provide evidence that determining the presence of hepatic steatosis and/or fibrosis potentially plays a role in risk stratification of mortality outcomes in patients with type 2 diabetes mellitus. | ko_KR |
dc.description.sponsorship | This work was supported by grants from the Seoul National University Hospital Research Fund (06‑2020‑4150) and from Liver Research Foundation of Korea as part of the Bio Future Strategies Research Project. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | BMC | ko_KR |
dc.subject | Diabetes | - |
dc.subject | Mortality | - |
dc.subject | Cause | - |
dc.subject | Steatosis | - |
dc.title | The association of fatty liver index and BARD score with all-cause and cause-specific mortality in patients with type 2 diabetes mellitus: a nationwide population-based study | ko_KR |
dc.type | Article | ko_KR |
dc.identifier.doi | 10.1186/s12933-022-01691-6 | ko_KR |
dc.citation.journaltitle | Cardiovascular Diabetology | ko_KR |
dc.language.rfc3066 | en | - |
dc.rights.holder | The Author(s) | - |
dc.date.updated | 2022-12-11T04:13:40Z | - |
dc.citation.number | 1 | ko_KR |
dc.citation.startpage | 273 | ko_KR |
dc.citation.volume | 21 | ko_KR |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.